Transgenic Group Inc. (TYO:2342)
Japan · Delayed Price · Currency is JPY 300.00
-3.00 (-0.99%)
At close: Feb 6, 2026
Transgenic Group Market Cap
Transgenic Group has a market cap or net worth of 5 billion as of February 6, 2026. Its market cap has increased by 71.43% in one year.
Market Cap
5.00B
Enterprise Value
5.70B
Revenue
12.92B
Ranking
n/a
PE Ratio
n/a
Stock Price
300.00
Market Cap Chart
Since July 2, 2003, Transgenic Group's market cap has decreased from 9.78B to 5.00B, a decrease of -48.90%. That is a compound annual growth rate of -2.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 5.00B | -1.64% |
| Dec 30, 2025 | 5.08B | 73.30% |
| Dec 30, 2024 | 2.93B | -33.27% |
| Dec 29, 2023 | 4.39B | -20.08% |
| Dec 30, 2022 | 5.50B | -27.38% |
| Dec 30, 2021 | 7.57B | -5.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OncoTherapy Science | 7.53B |
| Linical | 7.09B |
| PRISM BioLab Co.,LTD | 7.09B |
| Soiken Holdings | 6.72B |
| TMS Co., Ltd. | 6.60B |
| Noile-Immune Biotech | 6.45B |
| Kohjin Bio | 6.24B |
| Carna Biosciences | 5.76B |